Andrew Hinojos, DO
Clinical Cardiac Electrophysiology · Tulsa, OKNPI 1932513140
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (53.0%), food and beverage and education — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Medtronic at 58.6% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in OK, where the typical reported total is $22,745.
Across 209 payments — averaging $83.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$10K
- Abbott$3K
- Biotronik Inc.$2K
- Philips North America LLC$810
- Biosense Webster, Inc.$454
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$267
- plus $1K from 18 others
What the payments were for
- Grants$2601%
- Travel & lodging$9,27753%
- Food & beverage$7,23341%
- Education$7274%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 106 | $10,248 |
| Abbott | 23 | $2,600 |
| Biotronik Inc. | 15 | $1,841 |
| Philips North America LLC | 12 | $810 |
| Biosense Webster, Inc. | 16 | $454 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $267 |
| Amgen | 4 | $229 |
| GSK | 1 | $113 |
| Boston Scientific | 4 | $112 |
| Johnson & Johnson(2 entities) | 3 | $110 |
| Cardiva Medical, Inc. | 4 | $102 |
| AstraZeneca | 1 | $98 |
| Impulse Dynamics (USA) Inc. | 1 | $89 |
| Stereotaxis Inc | 1 | $86 |
| Abiomed | 2 | $83 |
| Edwards Lifesciences | 1 | $51 |
| Daiichi Sankyo Inc. | 2 | $51 |
| Angiodynamics, Inc. | 2 | $39 |
| Cvrx, Inc. | 1 | $23 |
| Baxter Healthcare | 1 | $20 |
| Cordis US CORP. | 1 | $20 |
| Bayer | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$1,673
- AVEIR$1,656
- EVERA MRI XT DR SURESCAN$1,357
- Arctic Front$969
- (9124) LM Undivided$586
- CoreValve Evolut$285
- HeartMate 3 Left Ventricular Assist Device$221
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$147
- AURORA EV-ICD MRI SURESCAN$126
- LINQ II$119
- BENLYSTA$113
- Enbrel$110
How this compares
$17,497 in reported general payments places this provider in the 35th percentile of 30 clinical cardiac electrophysiology providers in Oklahoma.
See all clinical cardiac electrophysiology providers in Oklahoma →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 101 | $79,677 |
| XareltoRivaroxaban | 47 | $59,829 |
| MultaqDronedarone Hcl | 31 | $28,747 |
| Flecainide Acetate | 57 | $3,528 |
| Metoprolol Succinate | 125 | $2,555 |
| Amiodarone Hcl | 104 | $1,691 |
| Omeprazole | 51 | $914 |
| Colchicine | 82 | $596 |
| Pantoprazole Sodium | 30 | $432 |
| Carvedilol | 37 | $329 |
| Furosemide | 77 | $228 |
| Lisinopril | 11 | $131 |
| Warfarin Sodium | 33 | $122 |
| Potassium Chloride | 41 | $106 |
| Metoprolol Tartrate | 15 | $94 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $110 | $59,82947 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 30 clinical cardiac electrophysiology providers in Oklahoma.
Other clinical cardiac electrophysiology in Tulsa
- David SandlerTulsa$86K
- Craig CameronTulsa$52K
- Vikram KatariTulsa$34K
- Venkatesh RaviTulsa$31K
- James ComanTulsa$24K
- Joseph GardTulsa$23K
- Ele WuTulsa$22K
- David OkadaTulsa$16K
- Warren JackmanOklahoma City$2.3M
- Sunny PoOklahoma City$260K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.